መነሻ › ዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ › Wisconsin › Milwaukee
በMilwaukee፣ WI ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ 16 ጥናቶች በMilwaukee እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Children's Hospital of Wisconsin, Milwaukee
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 ማይል ርቀት
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 ማይል ርቀት
- እና 3 ተጨማሪ
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Medical College of Wisconsin ( Site 0103), Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of ARC-02 in B-cell NHL
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Medical College of Wisconsin, Milwaukee
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
DALY II USA/ MB-CART2019.1 for DLBCL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Medical College of Wisconsin, Milwaukee
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 ማይል ርቀት
Long-term Follow-up Study of Patients Receiving CAR-T Cells
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- እና 4 ተጨማሪ
በሌሎች ከተሞች ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ ጥናቶች
- New York City, NY21 ጥናቶች
- Baldwin Park, CA19 ጥናቶች
- Chicago, IL18 ጥናቶች
- Los Angeles, CA17 ጥናቶች
- Houston, TX17 ጥናቶች
- Boston, MA16 ጥናቶች
- Nashville, TN15 ጥናቶች
- Portland, OR15 ጥናቶች
- Philadelphia, PA15 ጥናቶች
- Durham, NC14 ጥናቶች
- Dallas, TX13 ጥናቶች
- Seattle, WA12 ጥናቶች
በMilwaukee ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር23 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር22 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)22 ጥናቶች
- የሳንባ ካንሰር21 ጥናቶች
- Multiple Myeloma21 ጥናቶች
- የፕሮስቴት ካንሰር20 ጥናቶች
- ፎሊኩላር ሊምፎማ19 ጥናቶች
- የፓንክሪያስ ካንሰር18 ጥናቶች
- ኖን-ሆጅኪን ሊምፎማ18 ጥናቶች
- የእንቁላል ካንሰር17 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ17 ጥናቶች
- በርኪት ሊምፎማ16 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።